Search research articles
Contact Us
Filters
Showing results (121-130 of 164) with videos related to
Page
of 17
Sort By:
Advances in Radiation Oncology
|
October 30, 2018
Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy
Tommy Sheu, Sarah A Milgrom, Therese Y Andraos, et al.
Haematologica
|
April 7, 2018
A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma
Paolo Strati, Dai Chihara, Yasuhiro Oki, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 16, 2016
Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?
Zeinab Abou Yehia, George N Mikhaeel, Grace Smith, et al.
Cancer
|
May 21, 2016
Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma
Yago Nieto, Benigno C Valdez, Peter F Thall, et al.
Head & Neck
|
June 1, 2018
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma
Chelsea C Pinnix, Bouthaina S Dabaja, Sarah A Milgrom, et al.
Blood
|
August 27, 2005
Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center
Yasuhiro Oki, Hagop M Kantarjian, Xian Zhou, et al.
British Journal of Haematology
|
August 12, 2015
Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma
Dai Chihara, Barbara Pro, Sanam Loghavi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 15, 2015
Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas
Yago Nieto, Benigno C Valdez, Peter F Thall, et al.
Blood
|
October 18, 2017
Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation
Mani Akhtari, Sarah A Milgrom, Chelsea C Pinnix, et al.
British Journal of Haematology
|
December 23, 2017
Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma
Jay P Reddy, Mike Hernandez, Jillian R Gunther, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 164) with videos related to
Sort By:
Page
of 17
Advances in Radiation Oncology
|
October 30, 2018
Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy
Tommy Sheu, Sarah A Milgrom, Therese Y Andraos, et al.
Haematologica
|
April 7, 2018
A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma
Paolo Strati, Dai Chihara, Yasuhiro Oki, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 16, 2016
Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?
Zeinab Abou Yehia, George N Mikhaeel, Grace Smith, et al.
Cancer
|
May 21, 2016
Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma
Yago Nieto, Benigno C Valdez, Peter F Thall, et al.
Head & Neck
|
June 1, 2018
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma
Chelsea C Pinnix, Bouthaina S Dabaja, Sarah A Milgrom, et al.
Blood
|
August 27, 2005
Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center
Yasuhiro Oki, Hagop M Kantarjian, Xian Zhou, et al.
British Journal of Haematology
|
August 12, 2015
Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma
Dai Chihara, Barbara Pro, Sanam Loghavi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 15, 2015
Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas
Yago Nieto, Benigno C Valdez, Peter F Thall, et al.
Blood
|
October 18, 2017
Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation
Mani Akhtari, Sarah A Milgrom, Chelsea C Pinnix, et al.
British Journal of Haematology
|
December 23, 2017
Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma
Jay P Reddy, Mike Hernandez, Jillian R Gunther, et al.
Page
of 17